Get access

Possible role for nitric oxide dysregulation in critical illness myopathy

Authors

  • Margherita Capasso MD, PhD,

    1. Neuromuscular Diseases Unit, Center for Excellence on Aging, G. d'Annunzio University Foundation, and Clinica Neurologica, Ospedale “SS Annunziata”, Via dei Vestini, 66013 Chieti, Italy
    Search for more papers by this author
  • Antonio Di Muzio MD, PhD,

    1. Neuromuscular Diseases Unit, Center for Excellence on Aging, G. d'Annunzio University Foundation, and Clinica Neurologica, Ospedale “SS Annunziata”, Via dei Vestini, 66013 Chieti, Italy
    Search for more papers by this author
  • Assunta Pandolfi PhD,

    1. Department of Biomedical Sciences, Center for Excellence on Aging, G. d'Annunzio University Foundation, Chieti, Italy
    Search for more papers by this author
  • Marta Pace BS,

    1. Neuromuscular Diseases Unit, Center for Excellence on Aging, G. d'Annunzio University Foundation, and Clinica Neurologica, Ospedale “SS Annunziata”, Via dei Vestini, 66013 Chieti, Italy
    Search for more papers by this author
  • Pamela Di Tomo BS,

    1. Department of Biomedical Sciences, Center for Excellence on Aging, G. d'Annunzio University Foundation, Chieti, Italy
    Search for more papers by this author
  • Michele Ragno MD,

    1. Division of Neurology, C. and G. Mazzoni Hospital, Ascoli Piceno, Italy
    Search for more papers by this author
  • Antonino Uncini MD

    Corresponding author
    1. Neuromuscular Diseases Unit, Center for Excellence on Aging, G. d'Annunzio University Foundation, and Clinica Neurologica, Ospedale “SS Annunziata”, Via dei Vestini, 66013 Chieti, Italy
    • Neuromuscular Diseases Unit, Center for Excellence on Aging, G. d'Annunzio University Foundation, and Clinica Neurologica, Ospedale “SS Annunziata”, Via dei Vestini, 66013 Chieti, Italy
    Search for more papers by this author

Abstract

Muscle fiber inexcitability and myosin loss underlie weakness in critical illness myopathy (CIM). Nitric oxide (NO) takes part in the maintenance of muscle fiber resting potential and, in pathological conditions accompanied by oxidative stress, may damage proteins through peroxynitrite generation. Sepsis and other conditions associated with CIM may differentially affect expression of NO synthases (NOSs), so that both downregulation and upregulation with excessive peroxynitrite production can be hypothesized. In six patients with CIM we studied NOS1, NOS2, and NOS3 protein expression by immunohistochemistry and Western blot. To investigate peroxynitrite production, we performed immunohistochemistry for nitrotyrosine and measured nitrotyrosine levels by enzyme-linked immunosorbent assay. In three patients, sarcolemmal staining for NOS1 was selectively absent. In the others, it was absent in atrophic fibers and absent or reduced in non-atrophic fibers. Total NOS1 protein content was reduced by 41% in patients compared to controls, whereas no significant changes were found in levels and localization of NOS2, NOS3, and nitrotyrosine. Further studies are warranted to determine whether NOS1 loss plays a role in the pathophysiology of CIM, possibly reducing the release of NO at the sarcolemma and affecting muscle fiber excitability. Muscle Nerve, 2007

Ancillary